je.st
news
FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market
2014-05-09 16:12:50| drugdiscoveryonline News Articles
Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial scale manufacture of solid oral forms and non-sterile liquids.
Tags: site
us
france
market
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||